Fat Grafting for Treatment of Facial Scleroderma.
Adipose tissue
Cell therapy
Fat grafting
Microfat injection
Nanofat
Platelet-rich plasma
Stromal vascular fraction
Systemic sclerosis
Journal
Clinics in plastic surgery
ISSN: 1558-0504
Titre abrégé: Clin Plast Surg
Pays: United States
ID NLM: 0424767
Informations de publication
Date de publication:
Jan 2020
Jan 2020
Historique:
entrez:
20
11
2019
pubmed:
20
11
2019
medline:
26
2
2020
Statut:
ppublish
Résumé
Reparative, angiogenic, and immunomodulatory properties have been attributed to the cells in the adipose tissue-derived stromal vascular fraction. Because of these characteristics, in the last decade, fat grafting for treatment of autoimmune diseases has grown. This article focuses on systemic sclerosis, a rare autoimmune disease characterized by skin fibrosis and microvascular damage. Lesions of the face are almost always present; however, current therapy is insufficient and patients have considerable disability and social discomfort. This article presents our approach to using fat grafting in the face as an innovative and promising therapy for patients with systemic sclerosis.
Identifiants
pubmed: 31739892
pii: S0094-1298(19)30096-3
doi: 10.1016/j.cps.2019.08.016
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
155-163Informations de copyright
Copyright © 2019 Elsevier Inc. All rights reserved.